Apyx Medical
APYX
69 hedge funds and large institutions have $120M invested in Apyx Medical in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
5% more funds holding
Funds holding: 66 → 69 (+3)
1.33% more ownership
Funds ownership: 51.06% → 52.39% (+1.3%)
3% more capital invested
Capital invested by funds: $116M → $120M (+$3.92M)
0% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Silvercrest Asset Management
New York
|
+$4.63M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$2.5M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.01M |
| 4 |
Morgan Stanley
New York
|
+$836K |
| 5 |
RA
Royce & Associates
New York
|
+$805K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$681K |
| 2 |
PMG
ProVise Management Group
Clearwater,
Florida
|
-$426K |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$387K |
| 4 |
ACM
Archon Capital Management
Seattle,
Washington
|
-$386K |
| 5 |
RI
RTW Investments
New York
|
-$210K |
APYX Hedge Fund Activity: Q3 2019 in Review
69 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q3 2019, worth a combined $120M — up 3.4% from $116M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new APYX positions and 4 closed out — a net gain of 4 holders — while 22 added to existing stakes and 22 trimmed.
The largest buyer was Silvercrest Asset Management, opening a new position worth an estimated $4.63M. The largest seller was Dimensional Fund Advisors, cutting an estimated $681K.
- 69 institutional investors held Apyx Medical (APYX) as of Q3 2019, up from 66 in Q2 2019.
- Funds reported $120M of Apyx Medical stock for Q3 2019, up 3.4% quarter-over-quarter.
- 8 funds opened new Apyx Medical positions in Q3 2019 and 4 closed out, a net change of +4 holders.
- The largest Apyx Medical buyer in Q3 2019 was Silvercrest Asset Management, an estimated $4.63M added.
- The largest Apyx Medical seller in Q3 2019 was Dimensional Fund Advisors, an estimated $681K sold.
Based on aggregated 13F filings for Q3 2019.